Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS. - Wikidata - awgldk - TriplyDB

Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS.

Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS.

http://www.wikidata.org/entity/Q34019665

about

The rostral migratory stream plays a key role in intranasal delivery of drugs into the CNS Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation?Engineering therapies in the CNS: what works and what can be translated Cell based therapies for ischemic stroke: from basic science to bedside Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study Focused ultrasound-enhanced intranasal brain delivery of brain-derived neurotrophic factor.Intranasal delivery of cell-penetrating anti-NF-κB peptides (Tat-NBD) alleviates infection-sensitized hypoxic-ischemic brain injury Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study Engineering protein farnesyltransferase for enzymatic protein labeling applications.Intranasal nerve growth factor bypasses the blood-brain barrier and affects spinal cord neurons in spinal cord injury.Is tau a suitable therapeutical target in tauopathies?Brain delivery of small interfering ribonucleic acid and drugs through intranasal administration with nano-sized polymer micelles.Different expression patterns of Ngb and EPOR in the cerebral cortex and hippocampus revealed distinctive therapeutic effects of intranasal delivery of Neuro-EPO for ischemic insults to the gerbil brain.Endogenous repair signaling after brain injury and complementary bioengineering approaches to enhance neural regeneration Investigational agents for treatment of traumatic brain injury Peripheral administration of brain-derived neurotrophic factor to Rett syndrome animal model: a possible approach for the treatment of Rett syndrome Intranasal Delivery of A Novel Amnion Cell Secretome Prevents Neuronal Damage and Preserves Function In A Mouse Multiple Sclerosis Model.Synaptic Dysfunction in Alzheimer's Disease and Glaucoma: From Common Degenerative Mechanisms Toward Neuroprotection.Erythropoietin in stroke: quo vadis.Intranasal erythropoietin therapy in nervous system disorders.Intranasal delivery of stem cells to the brain.Intranasal delivery of therapeutic proteins for neurological diseases.Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism.The cerebrospinal fluid: regulator of neurogenesis, behavior, and beyond.Nanotechnology for CNS delivery of bio-therapeutic agents.Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF)Intranasal therapeutic strategies for management of Alzheimer's disease.Neurotrophin strategies for neuroprotection: are they sufficient?Intranasal gene delivery for treating Parkinson's disease: overcoming the blood-brain barrier.The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders.The role of growth factors as a therapeutic approach to demyelinating disease.Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states.Reduced spiral ganglion neuronal loss by adjunctive neurotrophin-3 in experimental pneumococcal meningitis.Delivery of brain-derived neurotrophic factor via nose-to-brain pathway.The neuroprotective roles of BDNF in hypoxic ischemic brain injury Nanoparticle-Based Therapeutics for Brain Injury.Delivery of Biologics Across the Blood-Brain Barrier with Molecular Trojan Horse Technology.An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.RGC Neuroprotection Following Optic Nerve Trauma Mediated By Intranasal Delivery of Amnion Cell Secretome.

P2860

Q21560838-683A78D0-F356-4640-9DCB-0FEF6CE221B9 Q26750898-AEC800D2-3C3C-4019-A5E5-2DBE06329A36 Q26826820-8BBE7999-0F0F-4A87-87D4-8A64CF1A50FE Q27025754-48771901-FEDC-4D20-9E9C-8B7844F603CD Q28487323-EA83FC36-0726-4A02-A9D9-69040A0332ED Q30380763-978B6FE4-8ED0-4C0C-84C0-A103AE135FC8 Q33781043-F7174AC9-BCD7-4D84-B83C-3F79FBCB85D0 Q33870071-5526B460-0664-40E6-942F-7A8003189D44 Q33921079-EB6B2533-B3F0-48BE-89BB-49213DBFDFE3 Q34096327-673EAD2F-7E77-4226-B0E7-AAD5757DCB79 Q34878802-9BE9CD46-3E62-4655-A897-1CAF8F2AA1F1 Q34961530-EE66429B-497A-4EE1-AE11-D7FE945A8803 Q35440761-D9D9F28A-918F-4EA2-9144-52665EB8491F Q35600150-7A42B661-E0E2-4423-A72C-238971824BA5 Q35611476-17D33E65-45BE-4F78-BF31-8FE978DE810D Q36577222-B92D1A4C-2A4E-4BAE-BC10-37612EA8A032 Q37615358-B17C631A-8783-42B9-9D8F-2BE058A7C6A7 Q37667218-576442BF-4AAF-4033-B2A5-C91A9A49D4AB Q37731533-65003ED6-0F59-4322-87E5-C40E6A01A9ED Q37818329-BD9190F0-59DC-430F-8321-87F934639D43 Q37854671-FCEE788B-0F45-4A97-8142-41F54C27FB27 Q37880893-181EE1BB-155E-4666-B272-28F6A8EFAB5E Q37924942-A6FB7133-3155-4626-86E3-A47691C2A110 Q37993422-CEFC25FB-39D0-48DA-9368-6BAC3D6BA0E1 Q38124859-F516C17E-A262-4D2C-AEE3-02B298217CA0 Q38140071-48B2F47F-DCA5-4FFF-B691-BB9EB3CD7F16 Q38168376-6CA38B57-FA9E-4D21-8497-A9171D55D2C2 Q38176935-3F4473C4-3D9A-407A-9714-C6BC6EF49C27 Q38194485-296129FB-7FC6-47B6-8381-8CEFC9716DAC Q38569775-3BEDCC48-8BB4-43CA-B1A7-F7D8B1E26823 Q38629117-9AE5C12E-1AD3-4097-B5DB-B6D8AF18F6FC Q38789326-5DD6ED46-95CF-4247-8619-964269F5AB2F Q41467643-1D8FE382-BAB2-4CF3-AF5F-FD73ED024F58 Q42040287-3E7D4CFE-1502-4341-82ED-EEF13DFA830A Q42380871-9E6B7B42-86BF-4A27-82D7-A38B16B9EE4A Q42409064-DC7B2EF4-2163-4128-92E2-9B905D275073 Q47442352-A41815E7-77D4-4616-89DE-963D1B54CDAF Q47606935-3D30E067-B709-4108-8182-E1C179352126 Q48497465-48A5F51B-9409-4869-B4FF-5726941468E6 Q55406585-C6DE4313-49A6-483C-A619-EF5BBAA3F5E6

P2860

Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS.

http://www.wikidata.org/entity/Q34019665

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS.

@ast

Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS.

@en

Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS.

@nl

type

label

Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS.

@ast

Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS.

@en

Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS.

@nl

prefLabel

Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS.

@ast

Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS.

@en

Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS.

@nl

P1433

Q34019665-C444C0CD-6C7C-4DB2-B4C9-38305EB0F570

P1476

Q34019665-DA06FF1A-5313-4491-8305-CDD28BF3EE3D

P2093

Q34019665-755439D8-C89A-4CD1-9ED3-39596F65EBEE

Q34019665-8E3856AB-07FC-45F4-B327-776167B22AE4

Q34019665-CE03D0F5-A699-4F12-B09E-5DADDD0D4661

Q34019665-D42D76E6-DD40-4B5D-82F3-735CD044D426

Q34019665-DEF0D967-2AAA-4169-95C3-1207F85D7222

Q34019665-F2E1F520-0B8F-4237-9330-C5C23B628A65

P2860

Q34019665-0389CB0C-C592-4A74-8534-C9C040C8C187

Q34019665-064F9BB4-7A0F-4D95-912E-5923F87654AC

Q34019665-08F39584-0E34-4EB2-B84D-7530D4C02607

Q34019665-0A0A3672-34F9-4B11-A8C2-F38296C694DC

Q34019665-0AD5DCA5-24B3-4FEC-96F2-FBD58C6C7274

Q34019665-0B7023E3-EDDE-4CD3-8E52-CB35A55A86AF

Q34019665-0C248E69-EA2C-4260-8837-6863B1CB95AD

Q34019665-0E87782C-2E18-420B-BEC8-602C504046FD

Q34019665-10FF6141-C0EB-4698-AC35-BA7CB5ECA25A

Q34019665-127551C2-4FD6-435E-B380-07DBEF9DED25

P304

Q34019665-C7FD5BAD-8A3F-4A18-B667-E08239AEEFC5

P31

Q34019665-3E8DE3CF-C82A-4FC8-AAC7-B2C8510DB1E6

P356

Q34019665-B5167499-77FB-4EFF-9B88-9798CDED82F7

P433

Q34019665-3EFC0014-3C91-427A-BEE1-2BD2A920A17D

P478

Q34019665-5663F159-BC9F-4BAB-859D-021117EF83CC

P577

Q34019665-F546AAAA-E477-4958-A07F-686C959446FC

P5875

Q34019665-E053EA15-F00D-40DB-A5CA-8511ED31525C

P698

Q34019665-BCFF3CE6-51B1-4044-BB0C-7ADC375DD6D6

P932

Q34019665-20A6105A-DF07-44AD-95D1-66E6D2E6D073

P356

10611860903318134

P1433

Journal of Drug Targeting

P1476

Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS.

@en

P2093

Abby A McDonald

http://www.w3.org/2001/XMLSchema#string

Leah R Hanson

http://www.w3.org/2001/XMLSchema#string

Linda K McLoon

http://www.w3.org/2001/XMLSchema#string

Michael S Lee

http://www.w3.org/2001/XMLSchema#string

Sandra R Alcalá-Barraza

http://www.w3.org/2001/XMLSchema#string

William H Frey

http://www.w3.org/2001/XMLSchema#string

P2860

New insights into brain BDNF function in normal aging and Alzheimer disease

Cellular mechanisms associated with spontaneous and ciliary neurotrophic factor-cAMP-induced survival and axonal regeneration of adult retinal ganglion cells

Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice

Sniffing neuropeptides: a transnasal approach to the human brain.

Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice.

Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches.

Intranasal insulin improves memory in humans.

Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations.

Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra.

Drug delivery to the central nervous system: a review.

P304

179-190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10611860903318134

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26874302

http://www.w3.org/2001/XMLSchema#string

P698

19807216

http://www.w3.org/2001/XMLSchema#string

P932

3732751

http://www.w3.org/2001/XMLSchema#string